Divalproex Sodium Tablet, Delayed Release
Product Images NDC 71335-2782

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71335-2782). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Divalproex Sodium De Figure 1)

Structure (Divalproex Sodium De Figure 1)
Not available.*
FDA Label Image

Figure1 (Divalproex Sodium De Figure 2)

Figure1 (Divalproex Sodium De Figure 2)
FDA Label Image

Figure2 (Divalproex Sodium De Figure 3)

Figure2 (Divalproex Sodium De Figure 3)
FDA Label Image

Figure3 (Divalproex Sodium De Figure 4)

Figure3 (Divalproex Sodium De Figure 4)
FDA Label Image

Figure4 (Divalproex Sodium De Figure 5)

Figure4 (Divalproex Sodium De Figure 5)
FDA Label Image

Label (Lbl713352782)

Label (Lbl713352782)
This text appears to be a description of pharmaceutical information for a specific product. It includes details about the content of each tablet - such as the active ingredient Divalproex Sodium USP, instructions for storage, manufacturer information, and dosage guidance. Additionally, it mentions a Medication Guide that should be dispensed to each patient. The text does not contain enough detail to specify the product name or purpose, but it provides important handling and usage information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.